Quantum Biopharma Ltd. Files 6-K, Incorporates Press Release
Ticker: QNTM · Form: 6-K · Filed: Aug 26, 2024 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Aug 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, registration-statement, press-release
TL;DR
Quantum Biopharma filed a 6-K on Aug 26, incorporating an Aug 23 press release into their F-3 registration. Standard update.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 26, 2024, incorporating by reference a press release issued on August 23, 2024. This filing is related to their Registration Statement on Form F-3 (SEC File No. 333-276264). The company is incorporated in A6 and its fiscal year ends on December 31.
Why It Matters
This filing indicates ongoing reporting and potential updates related to Quantum Biopharma's securities, which could impact investors tracking the company's regulatory compliance and public disclosures.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that incorporates a previously issued press release and references an existing registration statement, indicating standard corporate reporting rather than a significant new event.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- August 23, 2024 (date) — Date of press release
- August 26, 2024 (date) — Filing date
- 333-276264 (document_id) — Form F-3 SEC File Number
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed to report information that Quantum Biopharma Ltd. has made or will make public, file or submit to any stock exchange on which its securities are traded, or distribute or publish among its security holders, and is incorporated by reference into the Registrant's Registration Statement on Form F-3.
What was the previous name of Quantum Biopharma Ltd.?
The former company name was FSD Pharma Inc., with a date of name change on March 27, 2019.
When was the press release incorporated by reference issued?
The press release incorporated by reference was issued on August 23, 2024.
What is the SEC file number for the Registration Statement on Form F-3 mentioned in the filing?
The SEC file number for the Registration Statement on Form F-3 is 333-276264.
Where is Quantum Biopharma Ltd. incorporated and what is its fiscal year end?
Quantum Biopharma Ltd. is incorporated in A6 and its fiscal year ends on December 31.
Filing Stats: 248 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2024-08-26 06:18:04
Filing Documents
- fsd_6k.htm (6-K) — 11KB
- fsd_ex991.htm (EX-99.1) — 20KB
- 0001654954-24-011078.txt ( ) — 33KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: August 23, 2024 By: /s/ Nathan Coyle Nathan Coyle, Chief Financial Officer 3 EXHIBIT INDEX Exhibit Description Exhibit 99.1 Press Release dated August 23, 2024 – Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update 4